In vitro activity of polyhydroxycarboxylates against herpesviruses and HIV

被引：12

作者：

Meerbach, A ^{[1
]}

Neyts, J

Balzarini, J

Helbig, B

De Clercq, E

Wutzler, P

机构：

[1] Friedrich Schiller, Inst Antiviral Chemotherapy, Jena, Germany

[2] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium

来源：

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 2001年 / 12卷 / 06期

关键词：

polyanionic compounds; phenolic polymers; herpesvirus; cytomegalovirus; HIV; vaginal microbicide;

D O I：

10.1177/095632020101200603

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The antiviral activity of 17 polyhydroxycarboxylates derived from phenolic compounds was evaluated against herpesviruses and HIV. When present during virus adsorption several of the polymers exhibited potent activity against herpes simplex virus type 1 (HSV-1), HSV-2, thymidine kinase deficient HSV-1, human cytomegalovirus (HCMV) and HIV-1 and HIV-2 at concentrations that were not toxic to the host cells. A close correlation was found between the 50% inhibitory concentrations of the polyhydroxycarboxylates against HCMV-induced cytopathicity, their inhibitory effect on the expression of HCMV-specific immediate early antigens and their inhibitory effects on HCMV adsorption to the cells. The antiviral activity of the phenolic polymers was dependent on the presence of a sufficient number of carboxylic groups. The mechanism of antiviral action of the polyhydroxycarboxylates can thus be ascribed to inhibition of virus adsorption. This type of compound may have potential in a vaginal gel to prevent sexual transmission of HSV and HIV.

引用

页码：337 / 345

页数：9

共 29 条

[1] MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO [J].

BABA, M ;

PAUWELS, R ;

BALZARINI, J ;

ARNOUT, J ;

DESMYTER, J ;

DECLERCQ, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6132-6136

[2] SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS [J].

BABA, M ;

SNOECK, R ;

PAUWELS, R ;

DECLERCQ, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1742-1745

[3] The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model [J].

Bourne, N ;

Bernstein, DI ;

Ireland, J ;

Sonderfan, AJ ;

Profy, AT ;

Stanberry, LR .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) :203-205

[4] Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides [J].

Greenhead, P ;

Hayes, P ;

Watts, PS ;

Laing, KG ;

Griffin, GE ;

Shattock, RJ .

JOURNAL OF VIROLOGY, 2000, 74 (12) :5577-5586

[5] Anti-herpes simplex virus type 1 activity of humic acid-like polymers and their o-diphenolic starting compounds [J].

Helbig, B ;

Klocking, R ;

Wutzler, P .

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (03) :265-273

[6] IN-VITRO ACTIVITY OF A NOVEL SERIES OF POLYOXOSILICOVIRUSES, TUNGSTATES AGAINST HUMAN MYXOVIRUSES, HERPESVIRUSES AND RETROVIRUSES [J].

IKEDA, S ;

NEYTS, J ;

YAMAMOTO, N ;

MURRER, B ;

THEOBALD, B ;

BOSSARD, G ;

HENSON, G ;

ABRAMS, M ;

PICKER, D ;

DECLERCQ, E .

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (05) :253-262

[7] IN-VITRO AND IN-VIVO INHIBITION OF ORTHOMYXOVIRUS AND PARAMYXOVIRUS INFECTIONS BY A NEW CLASS OF SULFONIC-ACID POLYMERS INTERACTING WITH VIRUS-CELL BINDING AND/OR FUSION [J].

IKEDA, S ;

NEYTS, J ;

VERMA, S ;

WICKRAMASINGHE, A ;

MOHAN, P ;

DECLERCQ, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :256-259

[8]

KLOCKING R, 1975, MIKROBIOLOGIE, V15, P25

[9]

KLOCKING R, 1983, Z PHYSIOTHERAPIE, V35, P95

[10] Polyanions -: a lost chance in the fight against HIV and other virus diseases? [J].

Lüscher-Mattli, M .

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (04) :249-259

← 1 2 3 →